SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Aardvark Adventures -- Ignore unavailable to you. Want to Upgrade?

To: ~digs who wrote (1671)10/14/2005 9:10:03 AM
From: ~digs  Read Replies (2) | Respond to of 7944
 
AVII @ 2.70 .. daily pennant
stockcharts.com[w,a]daclyiay[pc40!c200!f][vc60][iut!La12,26,9!Ll14]&pref=G
-Oct. 14, 2005--AVI BioPharma, Inc. (Nasdaq:AVII - News) today announced results from four programs partially funded by The United States Department of Defense (DoD) and in collaboration with the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) at Fort Detrick, Md. AVI has successfully used its NEUGENE® antisense technology to combat the Ebola and Marburg viruses and to interrupt the cellular mechanism that ricin and anthrax toxins employ to induce lethal toxicity



To: ~digs who wrote (1671)10/14/2005 9:26:45 AM
From: ~digs  Read Replies (1) | Respond to of 7944
 
Hurricanes Katrina and Rita and a strike at an aircraft producer contributed to a 1.3% drop in industrial production in September, the Federal Reserve said Friday. It was the largest monthly drop since 1982. Economists surveyed by MarketWatch were expecting it to drop only 0.3%.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News